Anthony Cai is a Director of R&D Finance at Pfizer, where they focus on financial management and strategic support for projects in oncology, vaccines, and anti-infectives. Previously, they served as a Senior Financial Analyst at Genentech, leading financial analysis for key oncology drugs, and then held roles at BioMarin Pharmaceutical Inc. as Associate Director in FP&A and Finance Manager for enzyme replacement therapy. With a strong emphasis on teamwork and transparent communication, Anthony has managed multi-billion dollar R&D budgets and participated in M&A due diligence to assess financial risks and opportunities. They are currently pursuing an MBA in Finance at USC Marshall School of Business.
This person is not in any teams
This person is not in any offices